{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T15:10:19Z","timestamp":1774537819171,"version":"3.50.1"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T00:00:00Z","timestamp":1550188800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1151153"],"award-info":[{"award-number":["OPP1151153"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2,15]]},"DOI":"10.1093\/cid\/ciy878","type":"journal-article","created":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T15:29:48Z","timestamp":1539098988000},"page":"S27-S30","source":"Crossref","is-referenced-by-count":24,"title":["Introduction of Typhoid Conjugate Vaccines in Africa and Asia"],"prefix":"10.1093","volume":"68","author":[{"given":"Kathleen M","family":"Neuzil","sequence":"first","affiliation":[{"name":"Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J","family":"Pollard","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony A","family":"Marfin","sequence":"additional","affiliation":[{"name":"PATH, Seattle, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,2,15]]},"reference":[{"key":"key\n\t\t\t\t2019021500100060500_CIT0001","doi-asserted-by":"crossref","first-page":"e0005376","DOI":"10.1371\/journal.pntd.0005376","article-title":"The burden of typhoid fever in low- and middle-income countries: a meta-regression approach","volume":"11","author":"Antill\u00f3n","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t2019021500100060500_CIT0002","article-title":"Typhoid resurfaces in Harare","author":"Chipunza","year":"2018","journal-title":"The Herald"},{"key":"key\n\t\t\t\t2019021500100060500_CIT0003","volume-title":"Emergency typhoid vaccine drive underway in Hyderabad","year":"2018"},{"key":"key\n\t\t\t\t2019021500100060500_CIT0004","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/cid\/civ295","article-title":"Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study","volume":"61","author":"Mohan","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019021500100060500_CIT0005","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1016\/S0140-6736(17)32149-9","article-title":"Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella typhi: a randomised controlled, phase 2b trial","volume":"390","author":"Jin","year":"2017","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019021500100060500_CIT0006","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/cid\/cix1145","article-title":"Seroefficacy of Vi polysaccharide-tetanus toxoid typhoid conjugate vaccine (Typbar TCV)","volume":"67","author":"Voysey","year":"2018","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019021500100060500_CIT0007","volume-title":"Summary of the October 2017 meeting of the Strategic Advisory Group of Experts on Immunization","author":"SAGE","year":"2017"},{"key":"key\n\t\t\t\t2019021500100060500_CIT0008","volume-title":"Background paper to SAGE on typhoid vaccine policy recommendations","author":"SAGE Working Group on Typhoid Vaccines, WHO Secretariat","year":"2017"},{"key":"key\n\t\t\t\t2019021500100060500_CIT0009","volume-title":"Millions of children set to be protected against typhoid fever","author":"Gavi","year":"2017"},{"key":"key\n\t\t\t\t2019021500100060500_CIT0010","volume-title":"Typbar TCV\u00ae from Bharat Biotech, World\u2019s first typhoid conjugate vaccine prequalified by WHO","author":"Bharat Biotech International Ltd","year":"2018"},{"key":"key\n\t\t\t\t2019021500100060500_CIT0011","unstructured":"World Health Organization. Typhoid vaccine prequalified. Available at: http:\/\/www.who.int\/medicines\/news\/2017\/WHOprequalifies-breakthrough-typhoid-vaccine\/en\/. Accessed 15 January 2018."},{"key":"key\n\t\t\t\t2019021500100060500_CIT0012","doi-asserted-by":"crossref","first-page":"e0003748","DOI":"10.1371\/journal.pntd.0003748","article-title":"Rapid emergence of multidrug resistant, H58-lineage Salmonella typhi in Blantyre, Malawi","volume":"9","author":"Feasey","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t2019021500100060500_CIT0013","doi-asserted-by":"crossref","first-page":"e0177773","DOI":"10.1371\/journal.pone.0177773","article-title":"Lessons learnt from human papillomavirus (HPV) vaccination in 45 low- and middle-income countries","volume":"12","author":"Gallagher","year":"2017","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019021500100060500_CIT0014","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.4161\/hv.6.12.13076","article-title":"A policy framework for accelerating adoption of new vaccines","volume":"6","author":"Levine","year":"2010","journal-title":"Hum Vaccin"},{"key":"key\n\t\t\t\t2019021500100060500_CIT0015","doi-asserted-by":"crossref","DOI":"10.1201\/9781584888178","volume-title":"Cluster randomised trials","author":"Hayes","year":"2009"},{"key":"key\n\t\t\t\t2019021500100060500_CIT0016","doi-asserted-by":"crossref","first-page":"e016283","DOI":"10.1136\/bmjopen-2017-016283","article-title":"The STRATAA study protocol: a programme to assess the burden of enteric fever in Bangladesh, Malawi and Nepal using prospective population census, passive surveillance, serological studies and healthcare utilisation surveys","volume":"7","author":"Darton","year":"2017","journal-title":"BMJ Open"},{"key":"key\n\t\t\t\t2019021500100060500_CIT0017"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/68\/Supplement_1\/S27\/27783508\/ciy878.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T22:04:27Z","timestamp":1572041067000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/68\/Supplement_1\/S27\/5320189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,15]]},"references-count":17,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2019,2,15]]},"published-print":{"date-parts":[[2019,2,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciy878","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,2,15]]},"published":{"date-parts":[[2019,2,15]]}}}